{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:23:05Z","timestamp":1764044585849,"version":"3.40.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Egyptian National Cancer Institute"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jnci.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T12:07:06Z","timestamp":1542888426000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy \u2013 A pilot study"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6672-6336","authenticated-orcid":false,"given":"Ahmed Mostafa","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahia M.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaadin","family":"Hussien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Debaky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihab S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham S. Wahba","family":"Mikhael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar","family":"Moneer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"10","key":"10.1016\/j.jnci.2018.10.004_b0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1245\/ASO.2005.12.001","article-title":"Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions","volume":"12","author":"Stewart","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.jnci.2018.10.004_b0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4251\/wjgo.v2.i1.12","article-title":"Pathophysiology and biology of peritoneal carcinomatosis","volume":"2","author":"Kusamura","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.jnci.2018.10.004_b0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00268-010-0891-8","article-title":"Systematic review of prognostic factors related to overall survival in patients with stage IV colorectal cancer and unresectable metastases","volume":"35","author":"Stillwell","year":"2011","journal-title":"World J Surg."},{"issue":"5","key":"10.1016\/j.jnci.2018.10.004_b0020","doi-asserted-by":"crossref","first-page":"18632","DOI":"10.1038\/srep18632","article-title":"Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin","volume":"21","author":"Van Oudheusden","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnci.2018.10.004_b0025","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomized trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0030","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","author":"Spratt","year":"1980","journal-title":"Cancer Res"},{"key":"10.1016\/j.jnci.2018.10.004_b0035","first-page":"164","article-title":"Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture","volume":"32","author":"Sugarbaker","year":"1989","journal-title":"Can J Surg"},{"key":"10.1016\/j.jnci.2018.10.004_b0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.2042-7158.1994.tb03883.x","article-title":"Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy","volume":"46","author":"Kuzuya","year":"1994","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jnci.2018.10.004_b0045","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0050","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0055","series-title":"Peritoneal carcinomatosis: principles of management","first-page":"359","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","author":"Jacquet","year":"1996"},{"key":"10.1016\/j.jnci.2018.10.004_b0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.jnci.2018.10.004_b0065","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/bjc.2014.419","article-title":"Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone","volume":"111","author":"Mirnezami","year":"2014","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.jnci.2018.10.004_b0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejso.2010.05.007","article-title":"Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends","volume":"36","author":"Maggiori","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.jnci.2018.10.004_b0075","first-page":"99","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality","volume":"7","author":"Newton","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0080","first-page":"187","article-title":"Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma","volume":"23","author":"Laterza","year":"2009","journal-title":"In Vivo"},{"key":"10.1016\/j.jnci.2018.10.004_b0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/bjs.8908","article-title":"Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis","volume":"100","author":"Iversen","year":"2013","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.jnci.2018.10.004_b0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jso.23610","article-title":"Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high-volume disease and cure rate","volume":"110","author":"Cashin","year":"2014","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.jnci.2018.10.004_b0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jnci.2018.10.004_b0100","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"Da Silva","year":"2006","journal-title":"J Am Coll Surg"},{"issue":"6","key":"10.1016\/j.jnci.2018.10.004_b0105","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1245\/s10434-007-9350-7","article-title":"Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0110","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejso.2004.01.017","article-title":"The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer","volume":"30","author":"Carmignani","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0120","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multiinstitutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jclinpath-2011-200340","article-title":"Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis","volume":"65","author":"Verhulst","year":"2012","journal-title":"J Clin Pathol."},{"key":"10.1016\/j.jnci.2018.10.004_b0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00384-010-1037-z","article-title":"Signet-ring cell carcinoma of colorectum\u2013current perspectives and molecular biology","volume":"26","author":"Gopalan","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jnci.2018.10.004_b0135","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1245\/s10434-012-2321-7","article-title":"Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base","volume":"19","author":"Hyngstrom","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.jnci.2018.10.004_b0140","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","article-title":"Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol","volume":"20","author":"Kuijpers","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2018.10.004_b0150","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1245\/s10434-014-3985-y","article-title":"Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"22","author":"Baumgartner","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036218300621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036218300621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T11:24:29Z","timestamp":1694085869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1110036218300621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1110036218300621"],"URL":"https:\/\/doi.org\/10.1016\/j.jnci.2018.10.004","relation":{},"ISSN":["1110-0362"],"issn-type":[{"type":"print","value":"1110-0362"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy \u2013 A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Egyptian National Cancer Institute","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnci.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}